Cooper Net Profit Margin 2010-2024 | COO

Current and historical net profit margin for Cooper (COO) from 2010 to 2024. Net profit margin can be defined as net Income as a portion of total sales revenue. Cooper net profit margin for the three months ending January 31, 2024 was .
Cooper Net Profit Margin Historical Data
Date TTM Revenue TTM Net Income Net Margin
2024-01-31 $3.67B $0.29B 7.94%
2023-10-31 $3.59B $0.30B 8.21%
2023-07-31 $3.51B $0.28B 7.85%
2023-04-30 $3.43B $0.29B 8.43%
2023-01-31 $3.38B $0.38B 11.12%
2022-10-31 $3.31B $0.39B 11.67%
2022-07-31 $3.22B $0.43B 13.36%
2022-04-30 $3.14B $0.95B 30.20%
2022-01-31 $3.03B $0.94B 31.00%
2021-10-31 $2.92B $2.95B 100.75%
2021-07-31 $2.85B $2.92B 102.46%
2021-04-30 $2.66B $2.36B 88.50%
2021-01-31 $2.47B $2.25B 91.20%
2020-10-31 $2.43B $0.24B 9.83%
2020-07-31 $2.44B $0.28B 11.43%
2020-04-30 $2.54B $0.34B 13.53%
2020-01-31 $2.67B $0.45B 17.00%
2019-10-31 $2.65B $0.47B 17.57%
2019-07-31 $2.61B $0.45B 17.07%
2019-04-30 $2.59B $0.43B 16.46%
2019-01-31 $2.57B $0.37B 14.24%
2018-10-31 $2.53B $0.14B 5.53%
2018-07-31 $2.44B $0.13B 5.24%
2018-04-30 $2.34B $0.13B 5.60%
2018-01-31 $2.23B $0.18B 7.85%
2017-10-31 $2.14B $0.37B 17.48%
2017-07-31 $2.10B $0.35B 16.51%
2017-04-30 $2.06B $0.33B 16.06%
2017-01-31 $2.02B $0.30B 14.82%
2016-10-31 $1.97B $0.27B 13.92%
2016-07-31 $1.91B $0.25B 13.12%
2016-04-30 $1.85B $0.21B 11.18%
2016-01-31 $1.80B $0.19B 10.76%
2015-10-31 $1.80B $0.20B 11.35%
2015-07-31 $1.81B $0.20B 10.94%
2015-04-30 $1.78B $0.24B 13.54%
2015-01-31 $1.76B $0.26B 14.74%
2014-10-31 $1.72B $0.27B 15.73%
2014-07-31 $1.66B $0.30B 17.82%
2014-04-30 $1.64B $0.30B 18.10%
2014-01-31 $1.61B $0.29B 18.16%
2013-10-31 $1.59B $0.30B 18.64%
2013-07-31 $1.57B $0.31B 19.78%
2013-04-30 $1.54B $0.29B 18.79%
2013-01-31 $1.50B $0.27B 17.95%
2012-10-31 $1.45B $0.25B 17.23%
2012-07-31 $1.41B $0.23B 16.60%
2012-04-30 $1.38B $0.21B 15.26%
2012-01-31 $1.36B $0.19B 14.01%
2011-10-31 $1.33B $0.18B 13.16%
2011-07-31 $1.28B $0.17B 12.95%
2011-04-30 $1.23B $0.16B 13.20%
2011-01-31 $1.19B $0.13B 11.00%
2010-10-31 $1.16B $0.11B 9.67%
2010-07-31 $1.13B $0.09B 8.33%
2010-04-30 $1.12B $0.08B 6.80%
2010-01-31 $1.09B $0.10B 8.91%
2009-10-31 $1.08B $0.10B 9.35%
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $19.341B $3.593B
The Cooper Companies Inc, is a specialty medical device company operating on a global basis. Cooper has two business segments- CooperVision and CooperSurgical. CooperVision manufactures and sells a wide range of contact lenses. CooperVision develops manufactures and markets a broad range of single-use, two-week and monthly contact lenses, featuring advanced materials and optics. The company's products are primarily designed for solving vision challenges like astigmatism, presbyopia and ocular dryness.?CooperSurgical sells a variety of medical devices and surgical instruments that are primarily utilized by gynecologists and obstetricians.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $73.379B 20.59
Becton Dickinson (BDX) United States $68.292B 19.32
West Pharmaceutical Services (WST) United States $25.906B 46.43
Cardinal Health (CAH) United States $24.133B 13.80
Align Technology (ALGN) United States $20.439B 39.46
Labcorp (LH) United States $17.753B 15.28
Henry Schein (HSIC) United States $9.553B 16.99
DENTSPLY SIRONA (XRAY) United States $5.872B 15.20
Merit Medical Systems (MMSI) United States $4.758B 26.08
Patterson (PDCO) United States $2.308B 11.06
CONMED (CNMD) United States $2.301B 20.87
STAAR Surgical (STAA) United States $2.098B 80.57
Atrion (ATRI) United States $0.819B 43.73
Lifevantage (LFVN) United States $0.086B 11.11
Pro-Dex (PDEX) United States $0.067B 33.62
Biolase (BIOL) United States $0.005B 0.00